Hospitalizaciones y mortalidad por COVID-19 en pacientes con enfermedades inflamatorias reumáticas en Andalucía

Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet., 395, 514, 10.1016/S0140-6736(20)30154-9 Oran, 2020, Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review, Ann Intern Med., 173, 362, 10.7326/M20-3012 Semaan, 2020, Voices from the frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn health professionals facing the COVID-19 pandemic, BMJ Glob Health., 5, 10.1136/bmjgh-2020-002967 Li, 2020, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia, N Engl J Med., 382, 1199, 10.1056/NEJMoa2001316 Pranata, 2020, Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 - Systematic Review, Meta-analysis, and Meta-regression, J Stroke Cerebrovasc Dis., 29, 104949, 10.1016/j.jstrokecerebrovasdis.2020.104949 Saghazadeh, 2020, Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids, Int Immunopharmacol., 84, 106560, 10.1016/j.intimp.2020.106560 Calabrese, 2020, COVID-19 and your rheumatology patients, Cleve Clin J Med., 10.3949/ccjm.87a.ccc027 Pablos, 2020, Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases, Ann Rheum Dis., 79, 1170, 10.1136/annrheumdis-2020-217763 D'Silva, 2020, Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US’hot spot’, Ann Rheum Dis., 79, 1156, 10.1136/annrheumdis-2020-217888 Pablos, 2020, Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study, Ann Rheum Dis., 79, 1544, 10.1136/annrheumdis-2020-218296 Mena Vázquez, 2020, Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases, Int J Clin Pract., 75, e13707 Gianfrancesco, 2020, Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry, Ann Rheum Dis., 79, 859, 10.1136/annrheumdis-2020-217871 2020, Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance 2020, Información científico-técnica, enfermedad por coronavirus, COVID-19 2020, Procedimiento de actuación frente a casos de infección por el nuevo Coronavirus (SARS-CoV-2) Monti, 2020, Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies, Ann Rheum Dis., 79, 667, 10.1136/annrheumdis-2020-217424 Favalli, 2021, What is the true incidence of COVID-19 in patients with rheumatic diseases?, Ann Rheum Dis., 80, e18, 10.1136/annrheumdis-2020-217615 Favalli, 2020, Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis, J Rheumatol., 47, 1296, 10.3899/jrheum.200507 Wu, 2020, Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med., 180, 934, 10.1001/jamainternmed.2020.0994 Mehra, 2020, Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19, N Engl J Med., 382, e102, 10.1056/NEJMoa2007621 Al Hayek, 2020, Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia, Saudi Med J., 41, 1090, 10.15537/smj.2020.10.25419 Li, 2020, Clinical and CT features of the COVID-19 infection: comparison among four different age groups, Eur Geriatr Med., 11, 843, 10.1007/s41999-020-00356-5 Cabezudo-García, 2020, Incidence and case fatality rate of COVID-19 in patients with active epilepsy, Neurology., 95, e1417, 10.1212/WNL.0000000000010033 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet., 395, 1054, 10.1016/S0140-6736(20)30566-3 Kumar, 2021, Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19, Mol Cell Biochem., 476, 553, 10.1007/s11010-020-03924-2 Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med., 8, e21, 10.1016/S2213-2600(20)30116-8 Liu, 2020, Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis, CMAJ., 192, E734, 10.1503/cmaj.200647 Xu, 2020, Effective treatment of severe COVID-19 patients with tocilizumab, Proc Natl Acad Sci U S A., 117, 10970, 10.1073/pnas.2005615117 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet., 395, 497, 10.1016/S0140-6736(20)30183-5